Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
L01EE01 L01EE01 Trametinib
L01EE02 L01EE02 Cobimetinib
L01EE03 L01EE03 Binimetinib
L01EF L01EF Cyclin-dependent kinase (CDK) inhibitors
L01EF01 L01EF01 Palbociclib
L01EF02 L01EF02 Ribociclib
L01EF03 L01EF03 Abemaciclib
L01EG L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EG01 L01EG01 Temsirolimus
L01EG02 L01EG02 Everolimus
L01EH L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
L01EH01 L01EH01 Lapatinib
L01EH02 L01EH02 Neratinib
L01EJ02 L01EJ02 Fedratinib
L01EL L01EL Bruton's tyrosine kinase (BTK) inhibitors
L01EL01 L01EL01 Ibrutinib
L01EL02 L01EL02 Acalabrutinib
L01EX18 L01EX18 Avapritinib
L01X L01X Other antineoplastic agents
L01XA L01XA Platinum compounds
L01XA01 L01XA01 Cisplatin
L01XA02 L01XA02 Carboplatin
L01XA03 L01XA03 Oxaliplatin
L01XA04 L01XA04 Satraplatin
L01XA05 L01XA05 Polyplatillen
L01XB L01XB Methylhydrazines
L01XB01 L01XB01 Procarbazine
L01XC L01XC Monoclonal antibodies
L01XC01 L01XC01 Edrecolomab
L01XC02 L01XC02 Rituximab
Showing 30 of 6753 Records